Crystal structures of -[(4-phenyl-thia-zol-2-yl)carbamo-thio-yl]benzamide and -{[4-(4-bromo-phen-yl)thia-zol-2-yl]carbamo-thio-yl}benzamide from synchrotron X-ray diffraction.

The title compounds, CHNOS, (I), and CHBrNOS, (II), are potential active pharmaceutical ingredients. Compound (I) comprises two almost planar fragments. The first is the central (carbamo-thio-yl)amide (r.m.s. deviation = 0.038 Å), and the second consists of the thia-zole and two phenyl rings (r.m.s. deviation = 0.053 Å). The dihedral angle between these planes is 15.17 (5)°. Unlike (I), compound (II) comprises three almost planar fragments. The first is the central -(thia-zol-2-ylcarbamo-thio-yl)amide (r.m.s. deviation = 0.084 Å), and the two others comprise the bromo-phenyl and phenyl substituents, respectively. The dihedral angles between the central and two terminal planar fragments are 21.58 (7) and 17.90 (9)°, respectively. Both (I) and (II) feature an intra-molecular N-H⋯O hydrogen bond, which closes an (6) ring. In the crystal of (I), mol-ecules form hydrogen-bonded layers parallel to (100) mediated by N-H⋯S and C-H⋯O hydrogen bonds. In the crystal of (II), mol-ecules form a three-dimensional framework mediated by N-H⋯Br and C-H⋯O hydrogen bonds, as well as secondary S⋯Br [3.3507 (11) Å] and S⋯S [3.4343 (14) Å] inter-actions.